InvestorsHub Logo
Followers 14
Posts 649
Boards Moderated 0
Alias Born 04/03/2014

Re: None

Thursday, 02/25/2016 12:04:52 PM

Thursday, February 25, 2016 12:04:52 PM

Post# of 461946
BP is facing a huge patent cliff (many many blockbusters and prime drugs coming off patent) and poor results in their R&D departments (compared to much smaller but more agile and innovative companies) ...add to this the likely upcoming problems with drug pricing.. as a result BP is feeling stressed.... This is why they are now increasingly resorting to market manipulation (and colluding with various nefarious participants in the process) of small companies with promising drug tech ... this is not just AVXL but as Xena mentioned the whole lot of promising bios.....Their recent exesses will put this issue in the spotlight and it will soon self correct; but in the meantime, companies being continuously dogged by nefarious types, and continuing on after a big pullback, are an indication of where BP sees value... and make up for their own weak R&D programs,patent cliff, and cooling pricing climate....
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News